AcelRx Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

AcelRx Pharmaceuticals, Inc.

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for th…

Drug Manufacturers - Specialty & Generic
US, Hayward [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of ACRX's Analysis
CIK: - CUSIP: 00444T100 LEI: - UEI: -
Secondary Listings
ACRX has no secondary listings inside our databases.